Purpose: The Street Medicine Auto-Refraction Technology study is an efficient and cost-effective treatment of refractive error (RE) and identification of potential non-RE pathology in people experiencing homelessness (PEHs).
Design: Outreach evaluation for diagnosis and treatment.
Methods: The internal medicine physicians/staff team used a protocol designed by ophthalmology to screen and treat PEHs. First, the uncorrected visual acuity (ucVA) was measured, which was defined as a patient's visual acuity without the use of any glasses. Those with 2-line improvement on pinhole testing (phVA) underwent handheld portable autorefraction (AR). During a second encounter, glasses purchased from the AR measurements were distributed, and vision was remeasured with the new glasses or current corrected visual acuity (ccVA). Patients with a final VA ≥0.3 logMAR (equivalent to Early Treatment Diabetic Retinopathy Study 20/40) were referred to an ophthalmology clinic for further evaluation.
Results: This was a prospective study of 117 patients (226 eyes). ucVA was 0.64 logMAR (equivalent to Early Treatment Diabetic Retinopathy Study 20/87) for both the OD and the OS. A total of 90 of 98 (91.8%) patients successfully underwent AR; 80 of 88 (90.1%) patients received their glasses. For the 61 patients who completed their second visit, the average improvement in VA (ccVA - ucVA) was 5 lines. Twenty-three of 117 (19.7%) were referred to ophthalmology for further evaluation. Poststudy Likert surveys (1 = strongly disagree to 5 = strongly agree) showed patient satisfaction with the testing (4.7), the AR (4.6), seeing better (4.8), and doing activities with glasses (4.7). In addition, most patients agreed that they would not have obtained glasses without the study (4.7).
Conclusions: This is a new model to screen RE and provide affordable glasses to PEHs in a nonambulatory setting. Patients with potential non-RE can be sent for further evaluation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajo.2024.07.023 | DOI Listing |
Jpn J Ophthalmol
January 2025
Department of Ophthalmology, Eye center, China Medical University Hospital, Taichung City, Taiwan.
Purpose: To compare the efficac and safety of a dual-blade 20,000 cuts per minute (cpm) vitrectomy probe with a single-blade 10,000 cpm probe for primary rhegmatogenous retinal detachment (RRD).
Study Design: Prospective, randomized controlled clinical trial.
Methods: Evaluations were conducted preoperatively, intraoperatively, and at three months postoperatively.
Ophthalmol Ther
January 2025
Qvision, Department of Ophthalmology of VITHAS Almería Hospital, 04120, Almería, Spain.
The prevailing narrative in scientific literature has long overemphasized the role of ocular axes in intraocular lens (IOL) implantation, perpetuating misconceptions that have led to unnecessary exclusions of patients. Historical assumptions, coupled with inconsistent terminology and statistical inaccuracies, have muddled clinical decision-making. This review delves into these misconceptions, offering a critical reassessment of their relevance.
View Article and Find Full Text PDFNeurosurg Rev
January 2025
Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
The optimal therapeutic intervention for pediatrics with optic pathway glioma (OPG) remained controversial in the literature. Recently, due to substantial adverse events (AEs) of chemotherapy and its impact on children's lives, the efficacy of other options has been investigated. Bevacizumab (BVZ) is an anti-vascular endothelial growth factor (VEGF) agent that alters the lesion microenvironment.
View Article and Find Full Text PDFBr J Ophthalmol
January 2025
Fundacio Clinic per la Recerca Biomedica, Barcelona, Spain
Aim: To evaluate the impact of fluid volume fluctuations quantified with artificial intelligence in optical coherence tomography scans during the maintenance phase and visual outcomes at 12 and 24 months in a real-world, multicentre, national cohort of treatment-naïve neovascular age-related macular degeneration (nAMD) eyes.
Methods: Demographics, visual acuity (VA) and number of injections were collected using the Fight Retinal Blindness tool. Intraretinal fluid (IRF), subretinal fluid (SRF), pigment epithelial detachment (PED), total fluid (TF) and central subfield thickness (CST) were quantified using the RetinAI Discovery tool.
J AAPOS
January 2025
Keck School of Medicine of USC, Los Angeles, California; Division of Ophthalmology, Children's Hospital Los Angeles, Los Angeles, California. Electronic address:
Background: Cerebral/cortical visual impairment (CVI) is a leading cause of pediatric visual impairment in developed countries and is associated with neurologic conditions that may impair adaptive functioning or skills required to perform everyday tasks (eg, communication, socialization, and daily living skills). Adaptive behavior in children with CVI has not been systematically studied, and the relationship between visual function and adaptive function in CVI is unknown.
Methods: We prospectively recruited 49 children with CVI (mean age, 4 ± 3 years).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!